Question 1

How does Xysmalobium undulatum work to treat diarrhea?

Accepted Answer

Xysmalobium undulatum contains active pregnane glycosides and cardenolides, primarily uzarin and xysmalorin, which exert antispasmodic effects on intestinal smooth muscle. These compounds reduce hypermotility and cramping, helping normalize bowel function during episodes of diarrhea and dysentery. The mechanism involves inhibition of smooth muscle contraction, similar to other cardiac glycoside-containing plants. Evidence level C supports this traditional use, and the herb has been commercially formulated as an antidiarrheal remedy in Germany. The antispasmodic action addresses both the motility dysfunction and associated abdominal discomfort.

Question 2

Does Xysmalobium undulatum interact with digoxin or heart medications?

Accepted Answer

Yes, Xysmalobium undulatum has a significant drug interaction with cardiac glycoside medications including digoxin and digitalis. The plant contains cardenolides that can produce additive cardiac effects when combined with these medications, potentially leading to toxicity, arrhythmias, and other serious cardiovascular complications. This interaction is a well-documented contraindication. Patients currently taking any cardiac glycoside therapy should avoid Xysmalobium undulatum entirely. Always disclose all herbal supplement use to your healthcare provider, especially when taking prescription heart medications, to prevent dangerous interactions.

Question 3

What is the recommended dosage for Xysmalobium undulatum?

Accepted Answer

The standard adult dosage for Xysmalobium undulatum is 40 mg of uzarin extract (standardized formulation) taken three to four times daily. This standardized preparation ensures consistent levels of the active compound for therapeutic effect in treating diarrhea and digestive cramps. Commercial formulations in Germany follow this dosing protocol. Dosage should not exceed recommendations due to potential cardiac effects from overdose. This herb is contraindicated for children, and treatment duration should be limited. Always follow product labeling or consult a qualified healthcare practitioner for individualized guidance.

Question 4

Is Xysmalobium undulatum safe during pregnancy and breastfeeding?

Accepted Answer

No, Xysmalobium undulatum is contraindicated during pregnancy and should be strictly avoided by pregnant women. The plant contains cardiac glycosides and other active compounds that may pose risks to fetal development and pregnancy outcomes. Evidence level C does not support safety in pregnancy. Breastfeeding women should also avoid this herb due to insufficient safety data and potential transfer of active compounds through breast milk. Women who are pregnant, planning pregnancy, or breastfeeding should consult healthcare providers for alternative treatments for digestive complaints.

Question 5

What side effects can Xysmalobium undulatum cause?

Accepted Answer

Xysmalobium undulatum may cause mild side effects including nausea and headache in some individuals. More serious adverse effects can occur with overdose, particularly cardiac-related symptoms such as irregular heartbeat and other cardiovascular disturbances. The cardenolide content means that excessive dosing can lead to cardiac toxicity similar to digitalis overdose. Risk increases significantly when combined with cardiac medications or when recommended dosages are exceeded. Discontinue use immediately if concerning symptoms develop and seek medical attention. Evidence level C supports these safety considerations based on pharmacological understanding and traditional use data.

Xysmalobium Undulatum

Sources et citations

Résumé

Contexte

Usages traditionnels

Composés actifs

Mécanisme d'action

Preuves cliniques

Sécurité et effets indésirables

Interactions médicamenteuses

Synthèse des preuves

Sources PubMed

Sources gouvernementales